IRIS
CERONI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.600
AS - Asia 7.658
EU - Europa 6.737
SA - Sud America 815
AF - Africa 191
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 9
Totale 26.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.371
CN - Cina 3.963
SG - Singapore 1.689
IE - Irlanda 1.429
UA - Ucraina 1.080
DE - Germania 819
FI - Finlandia 793
HK - Hong Kong 756
RU - Federazione Russa 612
BR - Brasile 595
VN - Vietnam 590
SE - Svezia 578
FR - Francia 401
IT - Italia 398
GB - Regno Unito 375
IN - India 158
CA - Canada 124
ZA - Sudafrica 91
AR - Argentina 74
BD - Bangladesh 69
IQ - Iraq 58
JP - Giappone 58
MX - Messico 56
PK - Pakistan 45
VE - Venezuela 35
PL - Polonia 34
NL - Olanda 33
TR - Turchia 33
CO - Colombia 32
ES - Italia 31
BE - Belgio 30
ID - Indonesia 29
EC - Ecuador 28
AT - Austria 22
CL - Cile 20
MA - Marocco 20
PH - Filippine 20
UZ - Uzbekistan 19
AU - Australia 18
EG - Egitto 17
KE - Kenya 17
SA - Arabia Saudita 16
CZ - Repubblica Ceca 15
MY - Malesia 15
AE - Emirati Arabi Uniti 13
JO - Giordania 13
LT - Lituania 12
PY - Paraguay 12
AZ - Azerbaigian 11
IL - Israele 11
TN - Tunisia 11
PT - Portogallo 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
IR - Iran 9
JM - Giamaica 8
KG - Kirghizistan 8
NP - Nepal 8
AL - Albania 7
LV - Lettonia 7
OM - Oman 7
PA - Panama 7
BG - Bulgaria 6
CH - Svizzera 6
ET - Etiopia 6
HN - Honduras 6
KZ - Kazakistan 6
LB - Libano 6
PE - Perù 6
BO - Bolivia 5
BY - Bielorussia 5
GR - Grecia 5
KR - Corea 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
GE - Georgia 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RO - Romania 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
CG - Congo 3
EU - Europa 3
KW - Kuwait 3
LU - Lussemburgo 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CV - Capo Verde 2
GD - Grenada 2
GI - Gibilterra 2
Totale 25.989
Salva come PNG Salva come JPEG
Città #
Chandler 1.477
Dublin 1.423
Jacksonville 1.228
San Jose 1.001
Nanjing 935
Singapore 856
Ashburn 849
Hong Kong 739
Dallas 680
Beijing 507
Boardman 495
Nanchang 358
Princeton 284
Lawrence 276
Shenyang 268
Hebei 264
Wilmington 260
Lauterbourg 248
Changsha 240
Helsinki 237
Jiaxing 233
Los Angeles 227
Ho Chi Minh City 203
Medford 193
Ann Arbor 184
Munich 164
New York 160
Buffalo 159
Hangzhou 156
Tianjin 149
Council Bluffs 145
Hanoi 145
Moscow 129
Shanghai 103
Woodbridge 95
Milan 94
Johannesburg 70
Redondo Beach 68
Santa Clara 68
São Paulo 66
Pavia 60
Turku 58
Verona 55
Norwalk 53
Tokyo 53
Falkenstein 50
Dearborn 49
Toronto 48
Orem 46
Houston 43
Seattle 41
Da Nang 39
Montreal 34
Chicago 33
San Francisco 33
Frankfurt am Main 31
Haiphong 31
Zhengzhou 31
Rome 30
Brussels 29
Chennai 29
Brooklyn 28
Fairfield 28
Kunming 28
Stockholm 28
Warsaw 27
The Dalles 26
Boston 25
Des Moines 25
London 24
Nuremberg 24
Atlanta 23
Jinan 23
Guangzhou 22
Pune 21
Denver 20
Manchester 20
Rio de Janeiro 19
Falls Church 18
Tashkent 18
Auburn Hills 17
Poplar 17
Caracas 15
Dhaka 15
Phoenix 15
Washington 15
Baghdad 14
Lahore 14
Mumbai 14
Ningbo 14
Mexico City 13
Nairobi 13
Buenos Aires 12
Changchun 12
Hải Dương 12
Quito 12
Vienna 12
Belo Horizonte 11
Curitiba 11
Amman 10
Totale 17.027
Salva come PNG Salva come JPEG
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 161
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 156
2-DE AND MALDI-TOF-MS FOR A COMPARATIVE ANALYSIS OF PROTEINS EXPRESSED IN DIFFERENT CELLULAR MODELS OF AMYOTROPHIC LATERAL SCLEROSIS 152
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation 145
Activated lymphocytes in glioblastoma: significance for anti-tumoral immunity 144
Meningeal melanomatosis: a challenge for timely diagnosis. 144
A Randomized Phase III study: Comparison between Intra-venous and Intra-arterial ACNU Administration in Newly Diagnosed Primary Glioblastomas. 142
Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation 139
Analysis immunohistochemical of the HLA class I molecules in human glioma. 138
ISOLATION OF GENETIC MARKERS FROM HUMAN GLIOBLASTOMA CELLS BY DIFFERENTIAL DISPLAY TECHNIQUE 137
Autofluorescence-assisted delineation of glioblastoma resection margins. 137
Immunocytochemical detection of the Interleukin-2 receptors a and b on cell surface of normal and pathological cells. 137
Analysis of HLA antigen expression in formalin-fixed, paraffin-embedded astrocytic tumours. 136
Acute disseminated encephalomyelitis: Clinical, biological, neurophysiological and radiological prognostic markers 136
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation. 136
Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence. 134
Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression. 134
A prospective cohort study in JCV and non JCV-related leukoencephalopathies in HIV patients 134
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 131
Balance between proliferation and cell death in 8 selected supratentorial pilocytic astrocytomas. 130
Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes 130
Acute Disseminated Encephalomyelitis (ADEM): A Prospective Study on 122 Adults 130
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 130
Detection of a novel antineuronal antibody in paraneoplastic brainstem encephalitis. 129
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 129
Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia. 128
Trauma and amyotrophic lateral sclerosis: A case-control study from a population-based registry 126
Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma 125
Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence 125
Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication 125
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 124
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 124
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 123
Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins 122
Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients 122
Early cortical and late striatal diffusion restriction on 3T MRI in long-lived sporadic Creutzfeldt-Jakob disease case. 122
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation 121
Immunohistochemical and in situ hybridization localization of doppel protein as a new marker astrocytic tumour progression. 121
Analysis of HLA class I antigen and antigen-processing machinery components in human brain tumours. 121
A novel compound heterozygous mutation of C20orf54 gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family 120
Postinfectious neurologic syndromes: A prospective cohort study 119
About the original description of cerebellar tonsil herniation by Pierre Marie. 119
Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma. 118
Severe recurrent myelitis in patients with hepatitis C virus infection 118
Autofluorescence-based real time diagnosis for selective resection of tumors in neurosurgery. 118
Abbiategrasso brain bank protocol for collecting, processing and characterizing aging brains 118
Mini Nutritional Assessment May Identify a Dual Pattern of Perturbed Plasma Amino Acids in Patients with Alzheimer's Disease: A Window to Metabolic and Physical Rehabilitation? 118
Lateral gaze synkinesis on downward saccade attempts with paramedian thalamic and midbrain infarct 117
Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients. 117
Immunohistochemical expression of HLA antigens and components of the antigen processing machinery in astrocytic tumors. 116
Activity of protein phosphatase calcineurin in decreased in sporadic and familiar amyotrophic lateral sclerosis patients. 116
Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS 116
Leukocite derived microvescicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis. 116
Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories 115
Comparison of different immunohistochemical techniques for detection of anti-neuronal specific antibodies. 114
Experimental diets for the prevention of the development of familial amyotrophic lateral sclerosis 114
Cerebrospinal fluid ferritin in human disease. 114
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis 114
Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients 114
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 113
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 113
Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients 112
Heterogeneous distribution of amyotrophic lateral sclerosis patient with SOD-1 gene mulations: preliminary data on an Italian survey 112
Experimental diets for the prevention of the development of familial amyotrophic lateral sclerosis 111
Doppel protein as a new marker in astrocytic tumour progression 111
Immunohistochemical analysis to estimate actively proliferating, competent to proliferate and differentiated cell subsets in astrocytic tumours. 111
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 111
NMO-IgG-negative relapsing myelitis 110
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 110
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 109
Study of HLA class I antigen and antigen-processing machinery components in human glioblastoma. 108
Immunohistochemistry and in situ hybridization of “Doppel protein” in human astrocytic tumours 108
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 108
COVID-19 Pathology in the Lung, Kidney, Heart and Brain: The Different Roles of T-Cells, Macrophages, and Microthrombosis 107
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 107
Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan 106
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 106
Myelin basic protein purification in non denaturing conditions. 105
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 105
Amyotrophic lateral sclerosis and SOD1 gene: an overview 105
Interleukin-2 induces the growth of human glioblastoma cells in culture. 104
Severe recurrent myelitis in patients with hepatitis C virus infection patients 104
Clinical and MRI logitudinal study in two case-reports of long-lasting sCJD patients 104
Combined central and peripheral demyelination: comparison of adult and pediatric series 103
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. 101
Anomalie del deflusso venoso cerebrale in pazienti affetti da Sclerosi Multipla: valutazione con Doppler venoso e correlazioni cliniche 101
Disseminated encephalitis following streptococcal infection. 100
Optimizing separation efficiency of 2-DE procedures for visualization of different superoxide dismutase forms in a cellular model of amyotrophic lateral sclerosis 100
Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. 100
Doppel protein as a new marker in astrocytic tumour progression. 100
RNA-seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls 100
Dejerine's syndrome or Spille's syndrome? 99
Gene-environment interaction in parkinson's disease. The case of CYP2D6 polymorphism. 99
THE DDRT ANALYSIS AS A MOLECULAR TOOL TO IDENTIFY EXPRESSION DIFFERENCES AMONG GLIAL TUMORS 99
Late-onset myopathy after radiation therapy for thymoma in a young patient with myastenia gravis 99
Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis 99
DIFFERENTIAL EXPRESSION OF THE PRION GENE FAMILY IN GLIOBLASTOMA TUMORS. 98
Study in vitro of the effect of ACNU, carboplatin and etoposide on LAK cells. 98
Studio di polimorfismi dei geni RAGE, TNF e recettori (TNFR1 e TNFR2) in pazienti con Sclerosi Laterale Amiotrofica (SLA). 98
SELDI-TOF/MS detection of SOD1 enzyme expression levels: potential usefulness in the differential diagnosis of Amyotrophic Lateral Sclerosis 98
Totale 11.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.471
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.120 16 9 28 13 12 28 31 51 65 14 203 650
2022/20234.121 467 289 61 313 474 443 2 201 1.673 34 109 55
2023/20241.427 166 253 33 134 152 350 53 113 8 44 34 87
2024/20253.437 70 324 101 139 74 127 127 268 806 79 339 983
2025/20268.057 629 669 889 793 914 423 1.578 265 742 609 338 208
2026/202787 87 0 0 0 0 0 0 0 0 0 0 0
Totale 26.176